Wednesday, February 08, 2023 5:39:28 PM
All these things could add up to a 1000% gain, or it could come with a partnership at some point in the middle of all these things happening. That stated, I can't be very critical about whether that 1000% comes about based on a share price of $.73 or $.68, or slightly more or less. The gain will be tremendous, and perhaps most importantly, it won't stop there.
Just for the sake of discussing it, let's say we get the 1000% from $.70, i.e. a $7 stock price, it's not going to stay their very long. Sales of DCVax-L will build to blockbuster levels in GBM alone in the not too distant future, and higher prices will be justified even if no growth is anticipated beyond GBM. The real question IMHO is, will another 1000% be possible in the not too distant future from there, if so, what would it take. I believe that if overwhelming evidence is forthcoming on DCVax-L working in most other solid cancers we could be looking at that additional 1000%. Likewise if DCVax-Direct in trials proved beneficial in multiple cancers that were inoperable the same sort of gain could apply. What if it all came to pass, is another 1000% possible, it could be, perhaps in under a decade, if in fact DCVax-L and Direct had become a part of the SOC in the treatment of most solid cancers.
Let's not fret if we're $.72 one day and $.69 the next, that's happening with no good, or bad news. Let's think about where we'll be once we start getting the good news we know it coming. None of us would complain if we only saw 500% from that first 1000% this year, we know that with approvals and sales at some time that 1000% will come, and over time it will come again.
Gary
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM